Jan Meeldijk
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Cytotoxic lymphocytes counteract viral type I interferon immune evasion.
Journal: PLoS pathogens
Published: September 11, 2025
Dual targeting of CD155/TIGIT and PD-L1/PD-1 immune checkpoints potentiates NK cell-mediated cytotoxicity in medulloblastoma.
Journal: Neuro-oncology advances
Published: July 24, 2025
Chimeric antigen receptor-macrophages: Emerging next-generation cell therapy for brain cancer.
Journal: Neuro-oncology advances
Published: May 16, 2025
Undergraduate education as catalyst for public-private partnership in biotechnology.
Journal: Nature biotechnology
Published: February 14, 2025
Uniting education, research, healthcare, and society to advance women's heart health.
Journal: The Journal of experimental medicine
Published: October 15, 2024
Serpin B9 controls tumor cell killing by CAR T cells.
Journal: Journal for immunotherapy of cancer
Published: March 03, 2023
Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1.
Journal: Frontiers in immunology
Published: June 30, 2021
Extracellular Granzyme K Modulates Angiogenesis by Regulating Soluble VEGFR1 Release From Endothelial Cells.
Journal: Frontiers in oncology
Published: March 18, 2021
ARGX-117, a therapeutic complement inhibiting antibody targeting C2.
Journal: The Journal of allergy and clinical immunology
Published: February 27, 2020
Killer cell proteases can target viral immediate-early proteins to control human cytomegalovirus infection in a noncytotoxic manner.
Journal: PLoS pathogens
Published: August 01, 2019
Sialic Acid-Engineered IL4-10 Fusion Protein is Bioactive and Rapidly Cleared from the Circulation.
Journal: Pharmaceutical research
Published: June 17, 2019
Last Updated: 09/26/2026